Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bell

Showing results (121-130 of 1,348) with videos related to

Pageof 135
Sort By:
The American Journal of Cardiology|May 18, 2004
Advantages of a third-generation beta-blocker in patients with diabetes mellitusDavid S H Bell
British Medical Journal|April 1, 1978
Association between HLA-BW40 and alcoholic liver disease with cirrhosisH Bell, R Nordhagen
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: the heart and diabetesDavid S H Bell
Treatments in Endocrinology|March 4, 2005
A comparison of agents used to manage type 2 diabetes mellitus: need for reappraisal of traditional approachesDavid S H Bell
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 18, 2006
Do sulfonylurea drugs increase the risk of cardiac events?David S H Bell
Current Medical Research and Opinion|August 9, 2005
Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockadeDavid S H Bell
Diabetologia|January 20, 2007
Comment on: Distiller LA, Joffe BI (2006) From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic? Diabetologia 49:2793-2794D S H Bell
Case Reports in Endocrinology|January 11, 2013
Reversal of the Symptoms of Diabetic Neuropathy through Correction of Vitamin D Deficiency in a Type 1 Diabetic PatientDavid S H Bell
Annals of Internal Medicine|July 4, 2017
Oral Pharmacologic Treatment of Type 2 Diabetes MellitusDavid S H Bell
Case Reports in Endocrinology|March 19, 2015
Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic PatientDavid S H Bell
Pageof 135

Showing results (121-130 of 1,348) with videos related to

Sort By:
Pageof 135
The American Journal of Cardiology|May 18, 2004
Advantages of a third-generation beta-blocker in patients with diabetes mellitusDavid S H Bell
British Medical Journal|April 1, 1978
Association between HLA-BW40 and alcoholic liver disease with cirrhosisH Bell, R Nordhagen
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: the heart and diabetesDavid S H Bell
Treatments in Endocrinology|March 4, 2005
A comparison of agents used to manage type 2 diabetes mellitus: need for reappraisal of traditional approachesDavid S H Bell
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 18, 2006
Do sulfonylurea drugs increase the risk of cardiac events?David S H Bell
Current Medical Research and Opinion|August 9, 2005
Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockadeDavid S H Bell
Diabetologia|January 20, 2007
Comment on: Distiller LA, Joffe BI (2006) From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic? Diabetologia 49:2793-2794D S H Bell
Case Reports in Endocrinology|January 11, 2013
Reversal of the Symptoms of Diabetic Neuropathy through Correction of Vitamin D Deficiency in a Type 1 Diabetic PatientDavid S H Bell
Annals of Internal Medicine|July 4, 2017
Oral Pharmacologic Treatment of Type 2 Diabetes MellitusDavid S H Bell
Case Reports in Endocrinology|March 19, 2015
Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic PatientDavid S H Bell
Pageof 135